Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.

Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.

<h4>Background</h4> <p>Negative symptoms of schizophrenia represent deficiencies in emotional responsiveness, motivation, socialisation, speech and movement. When persistent, they are held to account for much of the poor functional outcomes associated with schizophrenia. There are...

Detaylı Bibliyografya
Asıl Yazarlar:	Barnes, T, Leeson, V, Paton, C, Costelloe, C, Simon, J, Kiss, N, Osborn, D, Killaspy, H, Craig, T, Lewis, S, Keown, P, Ismail, S, Crawford, M, Baldwin, D, Lewis, G, Geddes, J, Kumar, M, Pathak, R, Taylor, S
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	National Institute for Health Research 2016

Benzer Materyaller

Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
Yazar:: Thomas RE Barnes, ve diğerleri
Baskı/Yayın Bilgisi: (2016-04-01)

Long-term antidepressant treatment for negative symptoms in schizophrenia: the actions study
Yazar:: Barnes, T, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Disclosing the potential impact of placebo controls in antidepressant trials
Yazar:: Stephanie C. Chen, ve diğerleri
Baskı/Yayın Bilgisi: (2015-06-01)

Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
Yazar:: Thomas RE Barnes, ve diğerleri
Baskı/Yayın Bilgisi: (2017-09-01)

Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
Yazar:: Crawford, A, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Adverse effects from antidepressant treatment: Randomised controlled trial of 601 depressed individuals
Yazar:: Crawford, A, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response
Yazar:: Leucht, S, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

HOW IMPORTANT IS PLACEBO IN ANTIDEPRESSANT TRIALS?
Yazar:: Cipriani, A
Baskı/Yayın Bilgisi: (2010)

Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE)
Yazar:: MJ Crawford, ve diğerleri
Baskı/Yayın Bilgisi: (2012-02-01)

Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials.
Yazar:: Ludovic Trinquart, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Comparative efficacy of placebos in short-term antidepressant trials for major depression: a secondary meta-analysis of placebo-controlled trials
Yazar:: Lisa Holper, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson’s disease
Yazar:: A Schrag, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Severity of depression and response to antidepressants: GENPOD randomised controlled trial.
Yazar:: Wiles, N, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan.
Yazar:: Norio Sugawara, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Antidepressants for bipolar depression: a systematic review of randomized, controlled trials.
Yazar:: Gijsman, H, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial.
Yazar:: Lewis, G, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Individual differences in response to antidepressants: a meta-analysis of placebo-controlled randomized clinical trials
Yazar:: Maslej, MM, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Randomized controlled trials for schizophrenia: study designs targeted to distinct goals.
Yazar:: Stroup, T, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Efficacy of antidepressants over placebo is similar in two-armed versus three-armed or more-armed randomized placebo-controlled trials.
Yazar:: Ogawa, Y, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
Yazar:: Shiraishi Tetsuya, ve diğerleri
Baskı/Yayın Bilgisi: (2010-06-01)

Study of the use of antidepressants for depression in dementia: the HTA-SADD trial – a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine
Yazar:: S Banerjee, ve diğerleri
Baskı/Yayın Bilgisi: (2013-02-01)

Immunomodulatory Effects of Probiotic Supplementation in Schizophrenia Patients: A Randomized, Placebo-Controlled Trial
Yazar:: Jakub Tomasik, ve diğerleri
Baskı/Yayın Bilgisi: (2015-06-01)

Immunomodulatory Effects of Probiotic Supplementation in Schizophrenia Patients: A Randomized, Placebo-Controlled Trial
Yazar:: Jakub Tomasik, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Allowing for non-adherence to treatment in a randomized controlled trial of two antidepressants (citalopram versus reboxetine): an example from the GENPOD trial.
Yazar:: Wiles, N, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors.
Yazar:: Leucht, S, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors
Yazar:: Leucht, S, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Efficacy and Safety of Low-Dose Brexpiprazole for Acute Schizophrenia: Meta-Analysis of Randomized Placebo-Controlled Trials
Yazar:: Zhao M, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01)

Risperidone versus placebo for aggression following traumatic brain injury: a feasibility randomised controlled trial
Yazar:: Paul Bassett, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

The MATISSE study: a randomised trial of group art therapy for people with schizophrenia
Yazar:: Crawford Mike J, ve diğerleri
Baskı/Yayın Bilgisi: (2010-08-01)

Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysis
Yazar:: Leucht, S, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Adjunctive simvastatin treatment in schizophrenia patients; a double blind randomized and placebo controlled trial
Yazar:: Somaieh Ashrafi, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies
Yazar:: Furukawa, T, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Reactions to treatment debriefing among the participants of a placebo controlled trial
Yazar:: Crawford Fay, ve diğerleri
Baskı/Yayın Bilgisi: (2005-04-01)

Placebo-controlled trial of cytisine for smoking cessation.
Yazar:: West, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

The debate over placebo-controlled trials.
Yazar:: Frankllin Miller
Baskı/Yayın Bilgisi: (2005-06-01)

The debate over placebo-controlled trials.
Baskı/Yayın Bilgisi: (2005-06-01)

The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial
Yazar:: Mike J. Crawford, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

Efficacy and tolerability of lurasidone in schizophrenia: A systematic review and meta-analysis of short-term, randomized, placebo controlled trials
Yazar:: K. Hagi, ve diğerleri
Baskı/Yayın Bilgisi: (2021-04-01)

5-HT3 antagonist for cognition improvement in schizophrenia: a double blind, placebo-controlled trial
Yazar:: Neyousha Mohammadi, ve diğerleri
Baskı/Yayın Bilgisi: (2010-01-01)

5-HT3 antagonist for cognition improvement in schizophrenia: a double blind, placebo-controlled trial
Yazar:: Neyousha Mohammadi, ve diğerleri
Baskı/Yayın Bilgisi: (2010-01-01)